Clinical trials would need to assess both hemodynamic parameters and clinical outcomes including walking distance, pain scores, and amputation rates to establish therapeutic benefit
Expect to use it consistently for three to six months before evaluating results - hair biology is slow
Frequently Asked Questions Research References Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation (Hsieh et al., J Mol Med, 2017) BPC 157 promotes tendon healing via tendon outgrowth, cell survival and cell migration, FAK and paxillin phosphorylation (Chang et al., J Appl Physiol, 2011) Regeneration or Risk
It mimics a fragment of the native gastric protein, which may allow it to interact with receptors involved in tissue repair without provoking a strong immune response
Cagrilintide monotherapy at 4.5 mg weekly achieved 10.8% average weight loss over 26 weeks versus 3% with placebo in its Phase 2 dose-finding trial
Nearly all medicines in Spain must be purchased at a pharmacy
